← back to search

François P. Duhoux

Cliniques Universitaires Saint-Luc · BE
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, and Cancer Treatment and Pharmacology.
h-index
26
citations
4,220
works
270
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> Status
Journal of Clinical Oncology 2025cited by 19position: middledoi
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study
European Journal of Cancer 2025cited by 6position: middledoi
Breastfeeding after breast cancer in young <i>BRCA</i> carriers
JNCI Journal of the National Cancer Institute 2025cited by 4position: middledoi
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers
Breast Cancer Research 2024cited by 23position: middledoi
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial
Nature Communications 2023cited by 26position: middledoi
Machine Learning Algorithm to Estimate Distant Breast Cancer Recurrence at the Population Level with Administrative Data
Clinical Epidemiology 2023cited by 13position: middledoi
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases
JAMA Oncology 2022cited by 23position: middledoi
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
ESMO Open 2022cited by 12position: middledoi
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
npj Breast Cancer 2021cited by 38position: middledoi
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer
ESMO Open 2021cited by 20position: middledoi
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine 2019cited by 1,299position: middledoi
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer
JAMA Oncology 2016cited by 240position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2023–2023)Harlinde De Schutter · Stichting tegen Kanker1 papers (2023–2023) · 1 papers (2024–2024) · 1 papers (2023–2023) · 1 papers (2023–2023)Larissa Mourão · KU Leuven1 papers (2024–2024) · 1 papers (2024–2024)Colinda L. G. J. Scheele · Utrecht University1 papers (2024–2024)Marianela Vara-Messler · University of Padua1 papers (2024–2024) · 1 papers (2024–2024)Hans Wildiers · CHU Dinant Godinne UCL Namur1 papers (2023–2023)Jos Jonkers · Oncode Institute1 papers (2024–2024) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2024–2024) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2024–2024)Evandro de Azambuja · Twitter (United States)1 papers (2023–2023)Cédric van Marcke · UCLouvain1 papers (2024–2024)